Singapore markets open in 2 hours 46 minutes

Mithra Pharmaceuticals SA (0R91.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
6.41-0.09 (-1.31%)
At close: 06:18PM BST
Full screen
Previous close6.49
Open6.52
BidN/A x N/A
AskN/A x N/A
Day's range6.30 - 6.57
52-week range1.29 - 6.80
Volume2,150
Avg. volume10,298
Market capN/A
Beta (5Y monthly)0.45
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date08 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process

    Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of several binding offers, Mithra has selected the offer submitted by Gedeon Richter, which relates to Estetra SRL, Neuralis SA and specific assets held by Mithra R&D SA related to the E4 platform, as a basis for further negotiations and decided to grant exclusivity to Gedeon Richter for the purpose of such negotiations (up to 10 May

  • GlobeNewswire

    Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023

    Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full repayment of all creditors of Mithra, and, therefore, the offers do not allow to create value for Mithra’s shareholders at the present time.Mithra has requested the suspension of trading of its shares on Euronext Brussels pending continuing negotiations with offering parties.Mithra postpones the publi

  • GlobeNewswire

    Mithra secures court protection measures to advance monetization process

    Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra's complex therapeutics business.Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company's c